Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human/Feline CXCL12/SDF-1 beta (aa 22-93)
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 351FS010
missing translation for 'nonReturnableMessage'
missing translation for 'returnPolicyLabel'
Description
The Recombinant Human/Feline CXCL12/SDF-1 beta (aa 22-93) is derived from E. coli. The Recombinant Human/Feline CXCL12/SDF-1 beta (aa 22-93) has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. | |
| CXCL12/SDF-1 beta aa 22-93 | |
| E. coli-derived CXCL12/SDF-1 beta protein Lys22-Met93 | |
| Unconjugated | |
| 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 8 kDa | |
| 10μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |
missing translation for 'provideContentCorrection'
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
missing translation for 'productTitle'
Spot an opportunity for improvement?
missing translation for 'provideContentCorrection'